But he won't look at it because it doesn't have his name on it.
Friday, April 17, 2020
A Graph for the Covidiots
Including the Covidiot-in-Chief.
But he won't look at it because it doesn't have his name on it.
But he won't look at it because it doesn't have his name on it.
5 comments:
House Rules #1, #2 and #6 apply to all comments. Rule #3 also applies to political comments.
In short, don't be a jackass. THIS MEANS YOU!
If you never see your comments posted, see Rule #7.
All comments must be on point and address either the points raised in the blog post or points raised by commenters in response.
Any comments that drift off onto other topics are subject to deletion.
(Please don't feed the trolls.)
中國詞不評論，冒抹除的風險。僅英語。
COMMENT MODERATION IS IN EFFECT UFN. This means that if you are an insulting dick, nobody will ever see it.
Well, the graph isn't on FOX News, Britebart, or Qanon so it won't register with them. They'll just deny the facts with made up numbers just like their leader.
ReplyDeleteDale
Which made up numbers?
ReplyDeleteThe Death Rate?
The rate of people showing symptoms?
The date the"curve" starts?
The number of ventilators and hospital ICU suites we were gonna need?
Or one of the other overstated/inflated numbers?
It would appear, Comrade, it is just not simple enough.
ReplyDeleteLadies and Gentlemen, we present the evidence and ask it be entered as Item “B”.
ReplyDeleteSo, non-peer reviewed yet, but a Stanford University study in Santa Monica shows antibody response testing on slightly more than 3,000 people suggests that actual COVID-19 rate is 50 to 80 times higher than current estimates. There is good and bad news with this, if confirmed. The good news is we would be much closer to possible “herd immunity”, IF that proves applicable to this virus. The other good news is it would drive the death rate down significantly. The bad news is that is suggests a possible (significant) undercount in deaths from the virus so far.
ReplyDeleteGiven California was an early location for outbreak, if we take a conservative view, that would put 30-50 million cases of people with antibodies, which drops nicely into the 1-2% mortality rate expected based upon current “known” U.S. cases.